Growth stimulation of tumor-specific cytotoxic T lymphocytes on concanavalin A-immobilized carrier beads

Cytotechnology

Volumn 26, Issue 1, 1998, Pages 13-21

  Liu, Shu Qin ^a   Liu, Lin Shu ^b   Ohno, Tadao ^a  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^b Orquest Inc   (United States)

Author keywords

Concanavalin A; Cytotoxic T lymphocytes; Immobilization; Interleukin

Indexed keywords

EID: 6844237679     PISSN: 09209069     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007924430570     Document Type: Article

References (36)

1. Abo T and Balch CM (1982) Characterization of HNK-1+ (Leu-7) humna lymphocytes. II. Distinguishing phenotypic and functional properties of natural killer cells from activated NK-like cells. J Immunol 129: 1758-1761.
2. Baker PE, Gillis S and Smith KA (1979) Monoclonal cytolytic T-cell lines. J Exp Med 149: 273-278.
3. Bakker ABH, Schreurs MWJ, Tafazzul G, De Boer AJ, Kawakami Y, Adema GJ and Figdor CG (1995) Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-2.1 restricted antimelanoma CTL line. Int J Cancer 62: 97-102.
4. Crowley NJ, Darrow TL, Quinn-Alien MA and Seigler HF (1991) MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells - evidence for restriction by a dominant HLA-A allele. J Immunol 146: 1692-1699.
5. Fisk B, Blevins TL, Wharton JT and Ioannides CG (1995) Identification of an immunodominant peptide of HER2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines. J Exp Med 181: 2109-2117.
6. Freedman RS, Tomasovic B, Templin S, Atkinson EN, Kudelka A, Edwards CL and Platsoucas CD (1994) Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy. J Immunol Methods 167: 145-160.
7. Goedegebuure PS, Douville LM, Li H, Richmond GC, Schoof DD, Scavane M and Eberlein TJ (1995) Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study. J Clin Oncol 13: 1939-1949.
8. Groux H, Monte D, Plouvier B, Capron A and Ameisen JC (1993) CD3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: respective roles of interleukin-1, interleukin-2, interferon-g and accessory cells. Eur J Immunol 23: 1623-1629.
9. Gunther GR, Wang JL, Yahara I, Cunningham BA and Edelman GM (1973) Concanavalin A derivatives with altered biological activities. Proc Natl Acad Sci U.S.A. 70: 1012-1016.
10. Hay RJ, Park JG and Gazdar A (eds.) (1994) Atlas of human tumot cell lines, Academic Press, Inc. (C.A. U.S.A.).
11. Ioannides CG and Whiteside T (1993) T cell recognition of human tumors: implications for molecular immunotherapy of cancer. Clin Immunol Immunopath 66: 91-106.
12. Kawai K, Sasaki T, Saijo-Kurita K, Akaza H, Koiso K and Ohno T (1992) Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing deter-mined by lactate-dehydrogenase-release assay. Cancer Immunol Immunother 35: 225-229.
13. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Sakaguchi K, Appella E, Yannelli JR, Adema GJ, Miki T and Rosenberg SA (1994a) Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 91: 6458-6462.
14. Kawakami Y, Eliyahu S, Sakaguchi K, Robbins PF, Rivoltini L, Yannelli JR, Appella E and Rosenberg SA (1994b) Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 180: 347-352.
15. Lau LL, Jamieson BD, Somasundaram T and Ahmed R (1994) Cytotoxic T-cell memory without antigen. Nature 369: 648-652.
16. Liu SQ, Ito Y and Imanishi Y (1992) Cell growth on immobilized cell-growth factors; 4. Interactions of fibroblast cells with insulin immobilized on poly(methyl methacrylate) membrane. J Biochem Biophys Methods 25: 139-148.
17. Liu B, Farrington SM, Petersen GM, Hamilton SR, Parsons R, Papadopoulos N, Fujiwara T, Jen J, Kinzler KW, Wyllie AH, Vogelstein B and Dunlop MG (1995a) Genetic instability occurs in the majority of young patients with colorectal cancer. Nature medicine 1: 348-352.
18. Liu SQ, Saijo K, Todoroki K and Ohno T (1995b) Induction of human autologous cytotoxic T lymphocytes on formalin-fixed and paraffin-embedded tumour sections. Nature medicine 1: 267-271.
19. Liu LS, Liu SQ, Ng SY, Froix M, Ohno T and Heller J (1997) Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres. J Control Release 43: 65-74.
20. Mazumder A, Grimm EA and Rosenberg SA (1983) Characterization of the lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with phatohemagglutinin. J Immunol 130: 958-964.
21. Mazumder A, Grimm, EA, Zhang HZ and Rosenberg SA (1982) Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins. Cancer Res 42: 913-918.
22. Moudgil KD and Sercarz EE (1994) Can antitumor responses discriminate between self and nonself. Immunol Today 15: 353-355.
23. Mukherji B, Guha A, Chakraborty NG, Sivanandham M, Nashed AL, Sporn JR and Ergin MT (1989) Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. J Exp Med 169: 1961-1976.
24. Noms DA (1990) Cytokine modulation of adhesion molecules in the regulation of immunologic cytotoxicity of epidermal targets. J Invest Derm 95: 111S-120S.
25. Novogrodsky A and Katchalski (1971) Lymphocyte transformation induced by concanavalin A and its reversion by methyl-a-D-mannopyranoside. Biochim Biophys Acta 228: 579-583.
26. Powell AE and Leon MA (1970) Reverse interaction of human lymphocytes with the mitogen concanavalin A. Exp Cell Res 62: 315-325.
27. Quentmeier H, Klaucke J, Muhlradt PF and Drexler HG (1992) Role of IL-6, IL-2 and IL-4 in the in vitro induction of cytotoxic T cells. J Immunol 149: 3316-3320.
28. Reeke GN Jr, Becker JW, Cunningham BA, Gunther GR, Wang JL and Edelman GM (1974) Relationshs between the structure and activities of concanavalin A. Ann NY Acad Sci 234: 369-382.
29. Shinomura N, Bluestone JA and Sachs DH (1986) Cloned cytotoxic T lymphocytes that recognized an I-A region product in the context of a class I antigen. J Exp Med 163: 972-980.
30. Slingluff CL, Cox AL, Stover JMJ, Moore MM, Hunt DF and Engelhard AH (1994) Cytotoxic T-lymphocyte response to autologous human squamous cell cancer of the lung: epitope reconstitution with peptides extracted from HLA-Aw68. Cancer Res 54: 2731-2737.
31. Takayama T, Makuuchi M, Sekine T, Terui S, Shiraiwa H, Kosuge T, Yamazaki S, Hasegawa H, Suzuki K, Tamagata M, Fujii M, Tanaka T and Kakizoe T (1991) Distribution and therapeutic effect of intraarterially transferred tumor-infiltrating lymphocytes in hepatic malignantces. Cancer 68: 2391-2396.
32. Tjoa BA and Kranz DM (1994) Generation of cytotoxic T-lymphocytes to a self-peptide/class I complex: a model for peptide-mediated tumor rejection. Cancer Res 54: 204-208.
33. ven Nossel C, Miedema F, Brouwer M, de Rie MA, Aarden LA and van Lier RAW (1988) Regulatory properties of LFA-1a and b chain in human T-lymphocyte activation. Nature 333: 850-852.
34. Wolfel T, Herr W, Coulie P, Schmitt U, Buschenfelde KHM and Knuth A (1993) Lysis of human pancreatic adenocarcinoma cells by autologous HLA-class I-restricted cytolytic T-lymphocyte (CTL) clones. Int J Cancer 54: 636-644.
35. Wolfel T, Van Pel A, Brichard V, Schneider J, Seliger B, Meyer zum Buschenfelde KH and Boon T (1994) Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur J Immunol 24: 759-764.
36. Yahara I and Edelman GM (1972) Restriction of the mobility of lymphocyte immunoglobulin receptors by concanavalin A. Proc Natl Acad Sci USA 69: 608-612.